Silexion Therapeutics Corp (SLXN) Capital expenditures 2023–2025
Silexion Therapeutics Corp (SLXN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$9,000FY2025 · since FY2023: $12,000 → $9,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9,000 | -59.1% |
| FY2024 | $22,000 | +83.3% |
| FY2023 | $12,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice